Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.03M | 8.55M | 19.28M | 13.98M | 30.11M |
Gross Profit | 1.95M | 6.83M | 17.70M | 12.02M | 28.70M |
EBITDA | -18.83M | -24.68M | -32.78M | -33.98M | -11.80M |
Net Income | -8.32M | -27.62M | -35.58M | -38.13M | -2.52M |
Balance Sheet | |||||
Total Assets | 18.35M | 45.19M | 60.10M | 91.99M | 75.64M |
Cash, Cash Equivalents and Short-Term Investments | 11.80M | 29.68M | 43.48M | 69.81M | 40.73M |
Total Debt | 2.21M | 20.75M | 23.26M | 24.30M | 25.82M |
Total Liabilities | 9.22M | 30.41M | 35.12M | 34.21M | 35.53M |
Stockholders Equity | 9.52M | 14.78M | 24.98M | 57.78M | 40.12M |
Cash Flow | |||||
Free Cash Flow | -19.09M | -34.47M | -26.39M | -37.51M | -38.91M |
Operating Cash Flow | -19.09M | -34.41M | -26.28M | -37.31M | -38.70M |
Investing Cash Flow | 18.04M | -1.17M | 19.84M | 15.31M | 9.43M |
Financing Cash Flow | -16.35M | 20.50M | 83.00K | 50.53M | 15.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
52 Neutral | $7.61B | 0.10 | -63.03% | 2.08% | 16.34% | 0.32% | |
47 Neutral | $13.19M | ― | -7.72% | ― | 35.25% | 81.05% | |
40 Underperform | $18.44M | ― | -203.11% | ― | -41.45% | 40.69% | |
― | $7.48M | ― | -58.27% | ― | ― | ― | |
31 Underperform | $45.17M | ― | -576.46% | ― | ― | 38.50% | |
― | $187.96M | 0.07 | 57.63% | ― | ― | ― | |
39 Underperform | $94.63M | ― | -201.88% | ― | ― | ― |
DURECT Corporation received a notice from Nasdaq on January 9, 2025, indicating that its stock price had fallen below the minimum bid price requirement of $1.00 per share for 30 consecutive trading days. The company was initially given until July 8, 2025, to comply, and later received an additional 180-day grace period until January 5, 2026. DURECT plans to monitor its stock price and may implement a reverse stock split if necessary to meet the requirements, as failure to regain compliance could result in delisting.
The most recent analyst rating on (DRRX) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Durect stock, see the DRRX Stock Forecast page.